Barbara Ann Karmanos Cancer Institute [clinicaltrials_resource:a41eb6ce7de35f827e32b0f7a9bf3099]
Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00002547]Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma [clinicaltrials:NCT00002552]Pyrazoloacridine in Treating Women With Metastatic Breast Cancer [clinicaltrials:NCT00002585]clinicaltrials:NCT00002656Bryostatin 1 in Treating Patients With Relapsed Multiple Myeloma [clinicaltrials:NCT00002907]Bryostatin 1 in Treating Patients With Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia [clinicaltrials:NCT00002908]KRN5500 in Treating Patients With Metastatic Solid Tumors [clinicaltrials:NCT00002923]Bryostatin 1 in Treating Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00003171]Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer [clinicaltrials:NCT00003220]Fenretinide in Treating Patients With Solid Tumors [clinicaltrials:NCT00003250]Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer [clinicaltrials:NCT00003877]Bryostatin 1 in Treating Patients With Recurrent or Refractory Hodgkin's Disease [clinicaltrials:NCT00003936]Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV Melanoma [clinicaltrials:NCT00004022]BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy [clinicaltrials:NCT00004927]SB-715992 in Treating Patients With Metastatic or Unresectable Solid Tumors or Hodgkin's or Non-Hodgkin's Lymphoma [clinicaltrials:NCT00101244]17-AAG and Sorafenib in Treating Patients With Unresectable or Metastatic Solid Tumors [clinicaltrials:NCT00121264]clinicaltrials:NCT00527124clinicaltrials:NCT00768118Weight Loss Counseling for African American Women Who Are Breast Cancer Survivors [clinicaltrials:NCT00872677]Gene Expression Profiles in Patients With Metastatic Pancreatic Cancer [clinicaltrials:NCT00897741]clinicaltrials:NCT00942422Tacrolimus and Thymoglobulin, as GvHD Prophylaxis in Patients Undergoing Related Donor HCT [clinicaltrials:NCT01246206]clinicaltrials:NCT01468532Fosaprepitant Dimeglumine in Preventing Nausea and Vomiting in Patients With Gastrointestinal Cancer Receiving Combination Chemotherapy [clinicaltrials:NCT01504711]clinicaltrials:NCT01534143clinicaltrials:NCT01656304Cabozantinib-S-Malate in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer [clinicaltrials:NCT01812668]Bortezomib and Filgrastim in Promoting Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma Undergoing Stem Cell Transplant [clinicaltrials:NCT02037256]
location [clinicaltrials_vocabulary:location]
Barbara Ann Karmanos Cancer Institute [clinicaltrials_resource:a41eb6ce7de35f827e32b0f7a9bf3099]
Bio2RDF identifier
a41eb6ce7de35f827e32b0f7a9bf3099
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:a41eb6ce7de35f827e32b0f7a9bf3099
address [clinicaltrials_vocabulary:address]
identifier
clinicaltrials_resource:a41eb6ce7de35f827e32b0f7a9bf3099
title
Barbara Ann Karmanos Cancer Institute
@en
type
label
Barbara Ann Karmanos Cancer In ...... eb6ce7de35f827e32b0f7a9bf3099]
@en